ARGENX SE (ARGX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1033.15-1.93%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ARGX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -11.7% |
| Our one-year growth estimate | diamond | Not available |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 398 industry peers
Why it matters: Better performance may show that Argenx is doing well compared to other companies.
Watch forSector performance outperforms peers like LLY and JNJ by more than 5% over the next quarter.
Also watch forSector performance underperforms peers by more than 5% over the next quarter.
Why it matters: If revenue growth picks up, it could signal a stronger market for ARGX's products.
Supportive ifHealthcare sector revenue growth is speeding up again. It is now close to 12% year over year.
Worry ifHealthcare sector revenue growth remains below 9% year over year.
Why it matters: Earnings results will reveal how well ARGX is performing compared to peers.
Watch forEarnings report shows revenue growth exceeding 10% year over year.
Also watch forEarnings report shows revenue growth below 5% year over year.
Why it matters: A return to higher revenue growth would signal a positive shift in the sector's maturity phase.
Supportive ifQ2 revenue growth exceeds 9% year over year.
Worry ifQ2 revenue growth remains below 9% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$156 on $10,000 · ±1.6% | How much price usually moves either way. |
| Bad day | $299 loss on $10,000 · 3.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,858 loss on $10,000 · 28.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Revenue growth below the median could signal a slowdown in the sector. This would raise concerns about the company's growth potential.
Worry ifRevenue growth falls below the median growth rate for the health care sector.
Less concerning ifRevenue growth stays at or above the median growth rate for the health care sector.
Why it matters: If revenue growth falls below the median, it signals a potential slowdown in the sector.
Worry ifQ2 revenue growth reported below the median growth rate for the sector.
Less concerning ifQ2 revenue growth remains at or above the median growth rate for the sector.